Jamie Stiff

Jamie Stiff is an experienced professional in the healthcare and biotechnology sectors, currently serving as Managing Director at Genesys Capital since June 2002, focusing on developing emerging life science companies. Jamie holds directorship roles at EBT Medical, Inc., specializing in neuromodulation therapies, and Inversago Pharma, which is working on cannabinoid therapies for metabolic disorders. Additionally, Jamie is involved with multiple organizations, including BIOTECanada, Creative Destruction Lab, CCRM, and the MaRS Investment Accelerator Fund, providing advisory services on investment committees. Educational qualifications include an MBA in life sciences venture capital from the University of Toronto's Rotman School of Management and a Bachelor of Science in Biology/Genetics from Queen's University.